IA
CNMD icon

IFP Advisors’s CONMED CNMD Stock Holding History

IFP Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.59K Buy
293
+120
+69% +$4.32K ﹤0.01% 3425
2026
Q1 		$6.12K Buy
173
+11
+7% +$448 ﹤0.01% 3412
2025
Q4 		$6.58K Buy
162
+150
+1,250% +$6.53K ﹤0.01% 3274
2025
Q3 		$564 Buy
+12
New +$622 ﹤0.01% 4133
2025
Q2 		– Hold
0
– – – 3558
2023
Q1 		– Sell
-111
Closed -$8K – 3555
2022
Q4 		$8K Sell
111
-51
-31% -$4.23K ﹤0.01% 3496
2022
Q3 		$19K Sell
162
-1
-0.6% -$94 ﹤0.01% 3117
2022
Q2 		$19K Hold
163
– – ﹤0.01% 2874
2022
Q1 		$19K Buy
+163
New +$22.8K ﹤0.01% 2874
2020
Q1 		– Sell
-29
Closed -$2.67K – 2791
2019
Q4 		$3K Sell
29
-3
-9% -$320 ﹤0.01% 2355
2019
Q3 		$3K Buy
+32
New +$3K ﹤0.01% 2519

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

IFP Advisors's CNMD Position: Q2 2026 in Review

IFP Advisors increased its CONMED (CNMD) stake by 69% in Q2 2026, buying an estimated $4.32K and bringing the position to 293 shares worth $9.59K. The position accounts for ﹤0.01% of the portfolio, ranked #3425.

IFP Advisors first reported a position in CNMD in Q3 2019 and has held it in 10 quarters since. The position peaked at $19K in Q3 2022. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • IFP Advisors held 293 shares of CONMED worth $9.59K as of Q2 2026.
  • IFP Advisors bought 120 CONMED shares in Q2 2026, an estimated $4.32K.
  • CONMED made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3425 holding.
  • IFP Advisors first reported a position in CONMED in Q3 2019 and has held it in 10 quarters since.
  • IFP Advisors's CONMED position peaked at $19K in Q3 2022.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.